PetMed Express Statistics
Total Valuation
PetMed Express has a market cap or net worth of $28.63 million. The enterprise value is $15.97 million.
| Market Cap | 28.63M |
| Enterprise Value | 15.97M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PetMed Express has 21.05 million shares outstanding. The number of shares has increased by 2.40% in one year.
| Current Share Class | 21.05M |
| Shares Outstanding | 21.05M |
| Shares Change (YoY) | +2.40% |
| Shares Change (QoQ) | +3.09% |
| Owned by Insiders (%) | 9.64% |
| Owned by Institutions (%) | 19.05% |
| Float | 13.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.17 |
| Forward PS | n/a |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.68, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.68 |
| Quick Ratio | 0.36 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -198.86 |
Financial Efficiency
Return on equity (ROE) is -78.56% and return on invested capital (ROIC) is -302.82%.
| Return on Equity (ROE) | -78.56% |
| Return on Assets (ROA) | -20.05% |
| Return on Invested Capital (ROIC) | -302.82% |
| Return on Capital Employed (ROCE) | -120.19% |
| Weighted Average Cost of Capital (WACC) | 9.14% |
| Revenue Per Employee | $893,418 |
| Profits Per Employee | -$154,915 |
| Employee Count | 189 |
| Asset Turnover | 1.95 |
| Inventory Turnover | 9.07 |
Taxes
| Income Tax | -69,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.49% in the last 52 weeks. The beta is 0.84, so PetMed Express's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -44.49% |
| 50-Day Moving Average | 1.77 |
| 200-Day Moving Average | 2.34 |
| Relative Strength Index (RSI) | 17.36 |
| Average Volume (20 Days) | 130,327 |
Short Selling Information
The latest short interest is 569,173, so 2.70% of the outstanding shares have been sold short.
| Short Interest | 569,173 |
| Short Previous Month | 647,682 |
| Short % of Shares Out | 2.70% |
| Short % of Float | 4.30% |
| Short Ratio (days to cover) | 6.75 |
Income Statement
In the last 12 months, PetMed Express had revenue of $168.86 million and -$29.28 million in losses. Loss per share was -$1.38.
| Revenue | 168.86M |
| Gross Profit | 47.15M |
| Operating Income | -27.84M |
| Pretax Income | -29.35M |
| Net Income | -29.28M |
| EBITDA | -18.59M |
| EBIT | -27.84M |
| Loss Per Share | -$1.38 |
Balance Sheet
The company has $13.08 million in cash and $414,000 in debt, with a net cash position of $12.67 million or $0.60 per share.
| Cash & Cash Equivalents | 13.08M |
| Total Debt | 414,000 |
| Net Cash | 12.67M |
| Net Cash Per Share | $0.60 |
| Equity (Book Value) | 22.99M |
| Book Value Per Share | 1.09 |
| Working Capital | -12.99M |
Cash Flow
In the last 12 months, operating cash flow was -$23.81 million and capital expenditures -$3.96 million, giving a free cash flow of -$27.77 million.
| Operating Cash Flow | -23.81M |
| Capital Expenditures | -3.96M |
| Depreciation & Amortization | 9.25M |
| Net Borrowing | n/a |
| Free Cash Flow | -27.77M |
| FCF Per Share | -$1.32 |
Margins
Gross margin is 27.92%, with operating and profit margins of -16.49% and -17.34%.
| Gross Margin | 27.92% |
| Operating Margin | -16.49% |
| Pretax Margin | -17.38% |
| Profit Margin | -17.34% |
| EBITDA Margin | -11.01% |
| EBIT Margin | -16.49% |
| FCF Margin | n/a |
Dividends & Yields
PetMed Express does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.40% |
| Shareholder Yield | -2.40% |
| Earnings Yield | -102.26% |
| FCF Yield | -97.01% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | -4.31% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 4, 1999. It was a forward split with a ratio of 3:1.
| Last Split Date | Mar 4, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
PetMed Express has an Altman Z-Score of 1.85 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.85 |
| Piotroski F-Score | 2 |